Role of Olive leaves Zinc Oxide Nanoparticles in Alleviating The Molecular and Histological Changes of Kidney in Female Goats-Induced by Gentamicin (Part III)
Article Sidebar
Main Article Content
Abstract
This study aimed to investigate the protective influence of olive leave extract zinc oxide nanoparticles (OLEZnONPs) complex against gentamicin–induced kidney dysfunctions in goats. Twenty five adult female goats were randomly divided into five equal groups and treated as follows: control group (C) administered sterile distilled water (IM) for 10 days, group G administered 25 mg/kg BW gentamicin (IM) for 7 days, group Z administered 10 ìg/kg BW of OLEZnONPs (IP) for 3 days, group GTZ administered 25 mg/kg BW gentamicin (IM) for 7 days and then 10 ìg/kg BW of OLEZnONPs (IP) for 3 days, group GWZ administered 25 mg/kg BWs gentamicin (IM) and 10 ìg/kg BW of OLEZnONPs (IP) together for first 3 days and then followed by gentamicin only for 4 days. After seven days of the experiment, the gene expression of kidney injury molcule-1(KIM-1) and neutrophil gelatinase-association lipocalin (NGAL) gene expression of kidney tissue were measured. In addition, samples of kidney were obtained for histopathological examination. Gentamicin medication induced a marked elevation in kidney tissue KIM-1 and NGAL gene expression in G and GTZ groups compared to control and other groups. Intraperitoneal treatment of goats with OLEZnONPs did not significantly affect NGAL and KIM-1 gene expression in Z, GWZ, and control groups. Histologically, in contrast to control, gentamicin induced more extensive kidney damages such as necrotized glomeruli, atrophic glomeruli, and renal tubular epithelial necrosis, while it was found that these alterations in kidney tissues were
improved in goats given OLEZnONPs with gentamicin compared to group G. In conclusion, our results demonstrate that OLEZnONPs reduce the deleterious effects of gentamicin with significantly decreasing of KIM-1 and NGAL gene expression and remodeling the histological changes of kidney in goats.
Correspondence: [email protected]
Received: 14 Marvh 2020
Accepted: 27 July 2020
Published: 28 December 2020
Downloads
Article Details
How to Cite
References
Krause KM, Serio AW, Kane TR, Connolly LY. Aminoglycosides: An Overview. Cold Spring Harb Perspect Med. 2016;6(6): a027029.
WHO, World Health Organization. WHO model list of essential medicines (19th List) [Internet]. Geneva: April 2015. is a reprint of the text on the WHO Medicines website. Available from http://www.who.int/medicines/publications/essentialmedicines/en/
Gyselynckg AM, Forrey A, Cutler R. Pharmacokinetics of gentamicin: distribution and plasma and renal clearance. J. Infect. Dis. 1971; 124:70-76.
Akinbodewa AA, Okunola O. Concomitant gentamicin-induced nephrotoxicity and bilateral ototoxicity. Niger J Clin Pract [serial online]. 2016; 19 (4) :563-6. DOI: 10.4103/1119-3077.183312.
Udupaa V, Prakash V. Gentamicin induced acute renal damage and its evaluation using urinary biomarkers in rats. Toxicol Rep.2019; 6: 91–99. doi: 10.1016/ j.toxrep. 2018.11.015.
Lee HJ, Lee S, Chung CJ, Lee JH, Lee SC, Choi SR, et al. The synergistic effect of gentamicin and clindamycin on rocuronium-induced neuromuscular blockade. Korean J Anesthesiol.2013; 64(2): 143–151. doi: 10.4097/ kjae.2013.64.2.143.
Singh YN, Marshall IG, Harvey AL. Pre- and post junctional blocking effects of aminoglycoside, polymyxin, tetracycline and lincosamide antibiotics. Br J Anaesth. 1982, 54(12):1295-306.
Chen KS, Bach A, Shoup A, Winick NJ. Hearing loss and vestibular dysfunction among children with cancer after receiving aminoglycosides. Pediatr. Blood Cancer 60.2013; 1772–1777. doi:10.1002/pbc.24631.
O’Sullivan ME, Perez A, Lin R, Sajjadi A, Ricci AJ, Alan G, Cheng AG.Towards the prevention of aminoglycoside-related hearing loss. Front. Cell. Neurosci. 2017, https://Ichimura doi.org/10.3389/fncel.2017.00325.
Nielson DV, Fedosova M, Hjortda V, Jakobsen C. Is single-dose prophylactic gentamicin associated with acute kidney injury in patients undergoing cardiac surgery? A matched-pair analysis. J Thorac Cardiovasc Surg.2014;148 (4):1634-1639.
Lin YF, Chiu I.J, Cheng FU, Lee YH, Wang YJ, Hsu YH, et al. The role of hypoxia-inducible factor-1α in zinc oxide nanoparticle-induced nephrotoxicity in vitro and in vivo. Particle and Fibre Toxicology. 2016; 13:52.
Acharya C, Thakar H, Vajpeyee SK. A Study of Oxidative Stress in gentamicin induced nephrotoxicity and effect of antioxidant vitamin C in wistar rats. National Journal of Physiology, Pharmacol Pharm. 2013; 3(1):14 – 20.
Abd El-Fattah HM, El-Sheikh NM. Evaluation of chemoprotective role of N-acetylcysteine and vitamin E on gentamicin- induced nephrotoxicity. Aust J Basic Appl Sci.2012; 6(3): 263-270.
Anitha T, Dass SM. MorindacitrifoliaExtract Attenuates Gentamicin Induced Renal Damage in Rats. Bull. Env. Pharmacol. Life Sci. 2014;
(2): 32-38.
Havasi A, Borkan S.Apoptosis and acute kidney injury. Kidney Int. 2011; 80: 29–40.
Endre Z, Pickering J, Walker R, Devarajan P, Edelstein C, Bonventre J.Improved performance of urinary biomarkers of acute kidney injury in the critically ill by stratification for injury duration and baseline renal function. Kidney Int. 2012; 79: 1119–1130.
Mishra J, Mori K, Ma Q, Kelly C, Barasch J, Devarajan P. Neutrophil gelatinase-associated lipocalin: a novel early urinary biomarker for cisplatin nephrotoxicity. Am. J. Nephrol.2004; 24: 307–315.
Mori K, Lee HT, Rapoport D, Drexler IR, Foster K, Yang J. Endocytic delivery of lipocalinsiderophore- iron complex rescues the kidney from ischemia-reperfusion injury. J. Clin. Invest. 2005; 115: 610–621.
Ichimura T, Bonventre JV, Bailly V, Wei H, Hession CA, Cate RL,et al . Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury. J. Biol. Chem. 1998; 273:
–4142.
Ichimura T, Hung CC, Yang SA, Stevens JL, Bonventre JV. Kidney injury molecule-1; a tissue and urinary biomarker for nephrotoxicant induced renal injury. Am. J. Physiol. Ren. Physiol. 2004 ; 286: F552–563.
Asseldonk EJ, Humphreys BD, Gunaratnam L, Duffield JS, Bonventre JV. Kidney injury molecule-1 is a phosphatidylserine
receptor that confers a phagocytic phenotype on epithelial cells. J. Clin. Invest. 2008; 118: 1657–1668.
Flower DR, North AC, Sansom CE. The lipocalin protein family: structural and sequence overview. Biochim. Biophys. Acta. 2000; 1482: 9–24.
Rosi NL, Mirkin CA.Nanostructures in biodiagnostics. Chem. Rev. 2005; 105(4):1547–1562.
Mohammad V, Umar A, Hahn YB. ZnO nanoparticles: growth, properties, and applications. In: Umar, A., Hahn, Y.B. Editors. Metal Oxide Nanostructures and Their Applications. USA: American Scientific; 2010; p. 1–36.
Awwad AM, Albiss B, Ahmad L.Green synthesis, characterization and optical properties of zinc oxide nanosheets using Oleaeuropea leaf extract, Adv. Mat. Lett. 2014; 5(9): 520-524.
Varghese E, George M.Green synthesis of zinc oxide nanoparticles. IJARSE. 2015;4(1): 307-314.
Kaviyarasi T, Muthulakshmi B, Kavitha C.Green Synthesis and Characterization of Zinc nanoparticle using Aeglemarmelos leaf extract. International Journal of Chem. Tech. Research. 2017;10(15): 344-348.
Al-Ghareebawi AM, Al-Okaily BN, Ibrahim OMS. Characterization of zinc oxide nanoparticles by Olea europaea leaves extract (Part I). Ijas. 2020; 51(6): (In Press).
Livak, K.J.; Schmittgen, T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25: 402–408.
Luna LG. Manual of Histology Staining. Methods of Armed Forces. Institute of Pathology. (3rd edit). New York and London: McGraw-Hill Book Company;1968.
Vaidya VS, Ozer JS, Dieterle F, Collings FB, Ramirez V, Troth S, et al. Kidney injury molecule-1 outperforms traditional biomarkers of kidney injury in preclinical biomarker qualification studies, Nat. Biotechnol. 2010;28: 478–485.
Ozer JS, Dieterle F, Troth S, Perentes E, Cordier A, Verdes P, et al. A panel of urinary biomarkers to monitor reversibility of renal injury and a serum marker with improved potential to assess renal function. Nat. Biotechnol.2010; 28:486–496.
Prozialeck WC, Vaidya VS, Liu J, Waalkes MP, Edwards JR, Lamar PC.Kidney injury molecule-1 is an early biomarker of cadmium nephrotoxicity. Kidney Int.2007; 72:985–993.
Supavekin S, Zhang W, Kucherlapati R, Kaskel FJ, Moore LC, Devarajan P. Differential gene expression following early renal ischemia/reperfusion. Kidney Int. 2003;63: 1714–1724.
Devarajan P, Mishra J, Supavekin S, Patterson LT, Potter SS. Gene expression in early ischemic renal injury: clues towards pathogenesis, biomarker discovery, and novel therapeutics. Mol. Genet. Metab. 2003; 80: 365–376.
Schmidt-Ott KM, Mori K, Kalandadze A, Li JY, Paragas N, Nicholas T. Neutrophil gelatinaseassociatedlipocalin-mediated iron traffic in kidney epithelia. Curr Opin Nephrol Hypertens. 2006; 15: 442–449.
Schmidt-Ott KM, Mori K, Li JY, Kalandadze A, Cohen DJ, Devarajan P.Dual action of neutrophil gelatinase-associated lipocalin. J. Am. Soc. Nephrol. 2007; 18: 407–413.
McDuffie JE, Gao J, Ma J, La D, Bittner A, Sonee M, et al. Novel genomic biomarkers for acute gentamicin nephrotoxicity in dog.Open J Mol Integr Physiol. 2013;3: 125-133.
Nishihara K, Masuda S, Shinke H, Ozawa A, Ichimura T, Yonezawa A, et al .Urinary chemokine (C-C) motif ligand 2 (monocyte chemotactic protein-1) as a tubular injury marker for early detection of cisplatin nephrotoxicity. Biochem Pharmacol. 2013; 85: 570-582.
Baban B, Liu JY, Mozafari MS.Endoplas-mic reticulum stress response and inflammatory cyto-kines in type 2 diabetic nephropathy: Role of indoleamine 2,3-dioxygenase and programmed death-1. Exp Mol Pathol. 2013; 94: 343-351.
Ward PD, La D, McDuffie JE.Renal transporters and biomarkers in safety assessment, new in-sights into toxicity and drug testing. In: S. Gowder, Ed., InTech. 2013.
Aldahmash BA, El-Nagar DM, Ibrahim KE. Reno-protective effects of propolis on gentamicin-induced acute renal toxicity in swiss albino mice. Nefrologia. 2016; 36(6): 643–652.
Chen F, Smith R, Gu YZ, Collins ND, Nioi P. Toxicoepigenetic alteration of the kidney injury molecule 1 gene in gentamicin-exposed rat kidney. Toxicol Sci. 2010; 117: 375–380.
Qiu Y, Hong M, Li H, Tang N, Ma J, Hsu C. Time-series pattern of gene expression profile in gentamycin-induced nephrotoxicity. Toxicol Mech Methods. 2015; 24: 142–51.
Roudkenar MH, Halabian R, Bahmani P, Roushandeh AM, Kuwahara Y, Fukumoto M. Neutrophil gelatinase-associated lipocalin: a new antioxidant that exerts its cytoprotective effect independent on Heme Oxygenase-1. Free Radic Res. 2011; 45 (7): 810-819.
Zhao M, Zhou Y, Liu S, Li L, Chen Y, Cheng J, et al. Control release of mitochondria-targeted antioxidant by injectable self-assembling peptide hydrogel ameliorated persistent mitochondrial dysfunction and inflammation after acute kidney injury. Drug Deliv. 2018; 25 (1): 546-554.
Noorani A, Gupta K, Bhadada K, Kale M. Protective effect of methanolic leaf extract of Caesalpinia bonduc(L.) on gentamicin-induced hepatotoxicity and nephrotoxicity in rats. Iran J Pharmacol Ther. 2011; 10: 21–25.
Nale L, More P, More B, Ghumare B, Shendre S, Mote C.Protective effect of Carica papaya L. seed extract in gentamicin induced
hepatotoxicity and nephrotoxicity in rats. Int J. Pharm. Biol. Sci. 2012; 3: 508–515.
Ullah N, Khan M, Khan T, Ahmad W. Protective effect of Cinnamomumtamalaextract on gentamicin-induced nephrotic damage in rabbits. Trop J Pharm Res. 2013; 12: 215–219.
Sahu BD, Tatireddy S, Koneru M, Borkar RM, Kumar JM, Kuncha M. Naringin ameliorates gentamicin-induced nephrotoxicity and associated mitochondrial dysfunction, apoptosis and inflammation in rats: possible mechanism of nephroprotection. Toxicol Appl Pharmacol. 2014; 277: 8–20.
Medina J, Bolanos H, Mosquera‑Sanchez LP, Rodriguez‑Paez JE. Controlled synthesis of ZnO nanoparticles and evaluation of their toxicity in Musmusculusmice. Int Nano Lett. 2018; 8: 165–179.
Al-Ghasham A, Ata HS, El-Deep S, Meki AR, Shehada S. Study of protective effect of date and Nigella sativa on Aflatoxin B1 Toxicity. Int. J. Health Sci. (Qassim). 2008; 2(2): 26–44.
Esmaeillou M, Moharamnejad M, Hsankhani R, Tehrani AA, Maadi H.Toxicity of ZnO nanoparticles in healthy adult mice. Environ Toxicol Pharmacol. 2013; 35(1):67-71.
Yan G, Huang Y, Bu Q, Lv L, Deng P, Zhou J, et al. Zinc oxide nanoparticles cause nephrotoxicity and kidney metabolism alterations in rats. J Environ Sci Health A Tox Hazard Subst Environ Eng. 2012; 47(4): 577-88.
Teslariu O, Pasca AS, Mititelu-Tartau L, Schiriac CE, Gales C, Saftencu PM, et al. The protective effects of zinc in experimental gentamicin induced acute renal failure in rats. J Physiol Pharmacol. 2016; 67(5): 751-757.